$6MVenture, 10 June 2025
Funding supports clinical validation, regulatory submissions and commercial readiness ahead of a future Series A.
- Amount
- $6M
- Stage
- Venture
- Announced
- 10 June 2025
- Use of funds
- Funding supports clinical validation, regulatory submissions and commercial readiness ahead of a future Series A.
- Checked
- Announced by the company
- Sources
- 32 Biosciences raises $6M Series A for gut microbiome (date approx) businesswire.com
32 Biosciences raises $6M Series A for gut microbiome (date approx) pulse2.com